This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency of the U.S. government. The contract, valued at $224,944.00, was awarded to Sibtech, Inc. on September 8, 2014 and has a completion date of December 7, 2015. The contract aims to develop specific molecular imaging agents that can be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This research...
This is a $1,591,490.86 Firm Fixed Price SBIR Phase I contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a civilian agency, to Collagen Medical LLC, a for-profit limited liability company, to support the development of target-specific molecular imaging agents in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. The contract is set aside for small businesses. Collagen Medical has previously received federal grants from the National...
This is a $1,725,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services (HHS), to Ocean Nano TECH LLC, a woman-owned small disadvantaged business. The contract is for the development of targeted molecular imaging agents to detect high-risk atherosclerotic plaque, in combination with existing imaging modalities. Ocean Nano TECH LLC is a nanotechnology...
This federal contract award of $224,973 was made by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Nanohybrids Inc., a for-profit company. The contract is for the development of target-specific molecular imaging agents to detect high-risk atherosclerotic plaque, under the Small Business Innovation Research (SBIR) program. The contract is a Definitive Contract, Firm Fixed Price type, with a completion date of September 7, 2015. There is no set-aside designation...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute, part of the National Institutes of Health at the Department of Health and Human Services. The $399,989 Firm Fixed Price contract was awarded to Molecular Targeting Technologies, Inc. (MTTI) on September 18, 2017 to develop a cancer-selective, phosphatidylserine (PS)-targeted radiolabeled nanovesicle system for targeted radionuclide therapy of brain tumors. The contract has a...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Aphios Corp, a minority-owned for-profit small business. The contract has a ceiling value of $149,440 and a completion date of December 14, 2011. It was awarded on June 15, 2011 under the SBIR program to support research related to Topic 43. SBIR contracts provide early-stage funding to small businesses for the development of innovative...
<p>This is a $215,489.60 definitive contract award from the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to MRI Interventions Inc. for SBIR (Small Business Innovation Research) Topic 076, Phase II, for the development of an MRI Myocardial Biopsy Forceps. The contract is set aside for small businesses and has a period of performance ending on September 17, 2016. The contract is a cost-no-fee type, indicating the contractor is not receiving a fee for their efforts.</p>
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract, valued at $249,723.00, was awarded to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business located in Bloomfield Hills, Michigan. The contract is for research and development of a "Multiplex Label-Free Nanowell Technology...
This SBIR Phase I contract was awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to the small business TDA Research, Inc. The $300,000 firm fixed price contract is for developing innovations in oxygen delivery devices. The contract is a total small business set-aside. The original solicitation was part of the NIH and CDC SBIR program, which aims to stimulate innovation, strengthen the role of small businesses, and...
<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $279,113, was awarded to Gwathmey, Inc. on August 26, 2009 for biomedical (applied/exploratory) research. The contract has a firm fixed price pricing type and a completion date of September 30, 2010.</p>